TTS Overfladebehandling ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.8% 20.1% 23.3% 29.0% 18.3%  
Credit score (0-100)  19 6 3 1 7  
Credit rating  B C C C B  
Credit limit (kDKK)  0.0 -0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  3,458 95 0 0 0  
Gross profit  2,007 -16.8 -1.4 -1.3 -0.3  
EBITDA  -68.7 -35.6 6.6 -1.3 -0.3  
EBIT  -74.0 -35.9 2.6 -1.3 -0.3  
Pre-tax profit (PTP)  -74.8 -38.7 1.4 1.0 1.6  
Net earnings  -59.0 -31.4 0.8 1.2 1.6  
Pre-tax profit without non-rec. items  -74.8 -38.7 1.4 1.0 1.6  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  15.7 0.0 0.0 0.0 0.0  
Shareholders equity total  29.4 -2.0 -1.2 0.0 1.6  
Interest-bearing liabilities  0.0 0.0 0.0 0.5 0.0  
Balance sheet total (assets)  219 26.6 0.1 0.5 1.6  

Net Debt  -89.4 0.0 -0.1 0.3 -0.0  
 
See the entire balance sheet

Volume 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  3,458 95 0 0 0  
Net sales growth  194.6% -97.3% -100.0% 0.0% 0.0%  
Gross profit  2,007 -16.8 -1.4 -1.3 -0.3  
Gross profit growth  114.2% 0.0% 91.5% 6.5% 74.8%  
Employees  6 0 0 0 0  
Employee growth %  -14.3% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  219 27 0 0 2  
Balance sheet change%  -48.8% -87.9% -99.7% 533.8% 225.8%  
Added value  -74.0 -35.9 2.6 -1.3 -0.3  
Added value %  -2.1% -37.8% 0.0% 0.0% 0.0%  
Investments  10 -16 -4 0 0  

Net sales trend  1.0 -1.0 -2.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 -1.0 -2.0  

Profitability 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  -2.0% -37.6% 0.0% 0.0% 0.0%  
EBIT %  -2.1% -37.8% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -3.7% 213.3% -179.3% 100.0% 100.0%  
Net Earnings %  -1.7% -33.1% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  -1.6% -32.9% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  -2.2% -40.8% 0.0% 0.0% 0.0%  
ROA %  -22.4% -26.8% 28.7% 106.7% 153.8%  
ROI %  -55.4% -225.9% 20,941.5% 390.2% 153.8%  
ROE %  -54.2% -112.2% 6.1% 431.9% 153.0%  

Solidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  13.4% -7.1% -94.1% 0.0% 100.0%  
Relative indebtedness %  5.5% 30.2% 0.0% 0.0% 0.0%  
Relative net indebtedness %  2.9% 30.2% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  130.1% -0.1% -1.2% -24.7% 0.3%  
Gearing %  0.0% -2.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  692.7% 26,756.1% 14,239.0% 0.0% 3.3%  

Liquidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  1.1 0.9 0.1 1.0 0.0  
Current Ratio  1.1 0.9 0.1 1.0 0.0  
Cash and cash equivalent  89.4 0.0 0.1 0.2 0.0  

Capital use efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  2.1 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  5.9% 28.1% 0.0% 0.0% 0.0%  
Net working capital  13.7 -2.0 -1.2 0.0 1.6  
Net working capital %  0.4% -2.1% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  576 0 0 0 0  
Added value / employee  -12 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -11 0 0 0 0  
EBIT / employee  -12 0 0 0 0  
Net earnings / employee  -10 0 0 0 0